Great West Life Assurance CO Mirati Therapeutics, Inc. Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$41.99 - $62.38 $480,197 - $713,377	11,436 Added 238.0%	16,241 $948,000
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $51,708 - $84,351	1,860 Added 63.16%	4,805 $209,000
Q2 2023 Aug 10, 2023	BUY	$36.13 - $49.49 $25,327 - $34,692	701 Added 31.24%	2,945 $107,000
Q1 2023 May 12, 2023	BUY	$36.54 - $54.26 $4,421 - $6,565	121 Added 5.7%	2,244 $84,000
Q4 2022 Feb 10, 2023	BUY	$41.27 - $98.62 $2,022 - $4,832	49 Added 2.36%	2,123 $97,000
Q3 2022 Nov 01, 2022	BUY	$59.5 - $86.7 $123,403 - $179,815	2,074 New	2,074 $145,000
Q2 2022 Aug 09, 2022	BUY	$39.16 - $88.71 $1,174 - $2,661	30 Added 1.49%	2,042 $137,000
Q1 2022 May 12, 2022	SELL	$75.82 - $150.97 $4,018 - $8,001	-53 Reduced 2.57%	2,012 $176,000
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $3,960 - $5,708	30 Added 1.47%	2,065 $302,000
Q2 2021 Aug 11, 2021	SELL	$144.0 - $179.73 $26,928 - $33,609	-187 Reduced 8.42%	2,035 $329,000
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $16,686 - $23,269	105 Added 4.96%	2,222 $378,000
Q3 2020 Nov 17, 2020	SELL	$113.26 - $167.27 $349,180 - $515,693	-3,083 Reduced 59.29%	2,117 $351,000
Q3 2020 Nov 13, 2020	BUY	$113.26 - $167.27 $349,180 - $515,693	3,083 Added 145.63%	5,200 $863,000
Q2 2020 Aug 17, 2020	BUY	$72.01 - $120.39 $25,491 - $42,618	354 Added 20.08%	2,117 $240,000
Q4 2019 Feb 11, 2020	BUY	$70.76 - $128.86 $124,749 - $227,180	1,763 New	1,763 $227,000
Q3 2019 Oct 25, 2019	SELL	$77.91 - $109.6 $243,858 - $343,048	-3,130 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$43.65 - $78.95 $50,153 - $90,713	1,149 Added 58.0%	3,130 $229,000
Q2 2018 Aug 10, 2018	BUY	$26.05 - $52.4 $51,605 - $103,804	1,981 New	1,981 $97,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account